Skip to content

THD Versus Open Haemorrhoidectomy

Transanal Haemorrhoidal Dearterialization (THD) Versus Open Haemorrhoidectomy for the Treatment of Haemorrhoids. An Open Prospective Randomized Study.

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02061176
Enrollment
90
Registered
2014-02-12
Start date
2013-10-31
Completion date
2021-12-31
Last updated
2017-12-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemorrhoids

Keywords

Hemorrhoids, Haemorrhoids, Transanal Haemorrhoidal Dearterialization, Transanal Hemorrhoidal Dearterialisation, Open Haemorrhoidectomy, Open Hemorrhoidectomy

Brief summary

A randomised study comparing Transanal Haemorrhoidal Dearterialization (THD) and Open Haemorrhoidectomy (OH) for the treatment of prolapsing haemorrhoids. The primary aim of the study is to evaluate the long-term effect on haemorrhoidal symptoms one year postoperatively. Secondary endpoints are postoperative pain, complications, effect on anal continence, recovery and return to normal activity, quality of life and health cost analysis.

Interventions

PROCEDURETransanal Haemorrhoidal Dearterialization

Sponsors

Holbaek Sygehus
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* The patient has Grade III-IV haemorrhoids or Grade II haemorrhoids with bleeding resistant to rubber band ligation or sclerotherapy * The patient has a Haemorrhoidal Symptom Score of 4 or more * The patient has an American Society of Anaesthesiologists (ASA) score I-II * The patient's age is 18-85 years at inclusion * The patient has had a colonoscopy, sigmoidoscopy or rigid rectoscopy within 3 months before inclusion

Exclusion criteria

* The patient has had previous operation for haemorrhoids within the last 2 years * The patient has had previous operation for anal incontinence * The patient has an active anal fistula * The patient has an active anal fissure * The patient has anal incontinence for solid stools

Design outcomes

Primary

MeasureTime frameDescription
Haemorrhoidal Symptoms1-year and 5-years postoperativelyFive questions regarding haemorrhoidal symptoms (pain, bleeding, itching, soiling and prolapse) are used to grade the symptom load. Each symptom is graded from 0-4, giving a total score from 0-20. The symptom score is registered preoperatively, 3 and 12 months and 5 years postoperatively.

Secondary

MeasureTime frameDescription
Anal continence1-year and 5-years postoperativelyEffect on anal continence is evaluated by Wexner Anal Incontinence Score and Revised Faecal Incotinence Score (RFIS) preoperatively, 3- and 12 months and 5 years postoperatively.
Quality of Life1-year and 5-years postoperativelyQoL is evaluated using Short Health Scale, Short Form(SF)-36 and EQ-5D preoperatively, 1-year and 5-years postoperatively.
Postoperative pain14 days postoperativelyPostoperative pain is registered using visual analog scale (VAS), by the hospital staff in the immediate postoperative course during hospital stay and by the patient the first 14 days postoperatively.
Complications1-year and 5-years postoperativelyEarly and late complications are registered at 3 and 12 months and 5 years follow up.
Health cost analysis1-year and 5-years postoperativelyHealth cost analysis will be based on an estimate of the cost of the operations, recovery of the patients and effect (need for further procedures or medical care).

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 19, 2026